the aid library

LIST OPTIONS

Filter

6317

Download (333)

View PDF (509)

Understanding the Antibiotic Manufacturing Ecosystem

Wellcome Trust; Boston Consulting Group (2022) CC

A view of global supply chains, pressure points, and implications for antimicrobial resistance response

Download (289)

View PDF (325)

Biobehavioural Survey Guidelines - For Populations at risk for HIV

A. Abdul-Quader; M. Berry; T. Bingham; J. Burnett; et al. Centers for Diseases Control and Prevention; UNAIDS; World Health Organization; et al. (2017) C_WHO

Global HIV Strategic Information Working Group

Download (466)

View PDF (606)

The 90-90-90 Compendium. Vol. 2

Health System Trust (2017) C1

Vol. 2: Clinicians' Guide
Clinicians’ Guide is designed to assist busy medical practitioners in the field with patient management by providing current, essential, practical guidance and background, packaged into a single resource

Download (296)

View PDF (502)

WHO competency framework, risk communication and community engagement

World Health Organization WHO (2024) C_WHO

The risk communication and community engagement (RCCE) competency framework is a resource that details the essential behaviours and activities necessary for effective communication and engagement with communities before, during and after public health emergencies. The purpose of this framework is to... more

Download (342)

View PDF (621)

Guidelines for drinking-water quality: Small water supplies

World Health Organization WHO (2024) C_WHO

Small drinking-water supplies commonly experience operational, managerial, technical and resourcing challenges that impact their ability to deliver safe and reliable services. The needs and opportunities associated with these supplies therefore warrant explicit consideration in policies and regulati... more

Download (1120)

View PDF (1319)

A framework for malaria elimination

World Health Organization WHO (2017) C_WHO

The document provides guidance on the tools, activities and strategies required to achieve malaria elimination and prevent re-establishment of transmission in countries, regardless of where they lie across the spectrum of transmission intensity. It is intended to inform national malaria elimination ... more

Download (207)

View PDF (243)

Guidelines on Estimating the Size of Populations Most at Risk to HIV

UNAIDS; World Health Organization (2010) C_WHO

UNAIDS/WHO Working Group on Global HIV/AIDS and STI Surveillance

Download (465)

View PDF (693)

Therapeutics and COVID-19 (Living Guideline, 10 November 2023)

World Health Organization WHO (2023) C_WHO

WHO has updated its guidelines for COVID-19 therapeutics, with revised recommendations for patients with non-severe COVID-19. This is the 13th update to these guidelines. Updated risk rates for hospital admission in patients with non-severe COVID-19 The guidance includes updated risk rates for... hospital admission in patients with non-severe COVID-19. The current COVID-19 virus variants tend to cause less severe disease while immunity levels are higher due to vaccination, leading to lower risks of severe illness and death for most patients. This update includes new baseline risk estimates for hospital admission in patients with non-severe COVID-19. The new ‘moderate risk’ category now includes people previously considered to be high risk including older people and/or those with chronic conditions, disabilities, and comorbidities of chronic disease. The updated risk estimates will assist healthcare professionals to identify individuals at high, moderate or low risk of hospital admission, and to tailor treatment according to WHO guidelines: **High: **People who are immunosuppressed remain at higher risk if they contract COVID-19, with an estimated hospitalization rate of 6%. **Moderate: **People over 65 years old, those with conditions like obesity, diabetes and/or chronic conditions including chronic obstructive pulmonary disease, kidney or liver disease, cancer, people with disabilities and those with comorbidities of chronic disease are at moderate risk, with an estimated hospitalization rate of 3%. Low: Those who are not in the high or moderate risk categories are at low risk of hospitalization (0.5%). Most people are low risk. Review of COVID-19 treatments for people with non-severe COVID-19 WHO continues to strongly recommend nirmatrelvir-ritonavir (also known by its brand name ‘Paxlovid’) for people at high-risk and moderate risk of hospitalization. The recommendations state that nirmatrelvir-ritonavir is considered the best choice for most eligible patients, given its therapeutic benefits, ease of administration and fewer concerns about potential harms. Nirmatrelvir-ritonavir was first recommended by WHO in April 2022. If nirmatrelvir-ritonavir is not available to patients at high-risk of hospitalization, WHO suggests the use of molnupiravir or remdesivir instead. WHO suggests against the use of molnupiravir and remdesivir for patients at moderate risk, judging the potential harms to outweigh the limited benefits in patients at moderate risk of hospital admission. For people at low risk of hospitalization, WHO does not recommend any antiviral therapy. Symptoms like fever and pain can continue to be managed with analgesics like paracetamol. WHO also recommends against use of a new antiviral (VV116) for patients, except in clinical trials. The update also includes a strong recommendation against the use of ivermectin for patients with non-severe COVID-19. WHO continues to advise that in patients with severe or critical COVID-19, ivermectin should only be used in clinical trials. more

Download (324)

View PDF (327)

Human African trypanosomiasis. Seminar

Büscher P., Cecchi G., Jamonneau V. et al (2017) C2

The Lancet Volume 390, Issue 10110p2397-2409November 25, 2017. Human African trypanosomiasis (HAT), also called sleeping sickness, is a parasitic infection that almost invariably progresses to death, unless treatment is provided. HAT caused devastating epidemics during the 20th century. Thanks to ... more

Download (203)

View PDF (182)

NAPHS for all: a country implementation guide for national action plan for health security (‎NAPHS)‎ - Second edition
recommended

World Health Organization WHO (2025) C_WHO

Lessons learned from recent public health events such as the COVID-19 pandemic, Ebola virus disease, Zika virus disease outbreaks, and other public health threats, including earthquakes and floods, have highlighted the need for countries to continuously develop, strengthen, and maintain capacities r... more

Download (330)

View PDF (431)

What you get for your dollar, “Effective Altruism” — What it is, how philanthropic foundations use it and what are its risks and side-effects

Karolin Seitz (2019) C2

This briefing paper provides an overview of the approach underlying EA, how and by whom it is applied and its problems and consequences. It concludes that policy makers, rather than be guided by its assumptions and conclusions, must instead concentrate on understand-i... more

External Link

Trachoma Action Planning TAP

International Coalition for Trachoma Control ICTC (2022) CC

In 2011, ICTC developed a Trachoma Action Plan (TAP) planning guide to support national health officials in endemic countries. This resource was developed to complement the 2020 INSight roadmap by helping countries create specific national plans detailing how they will reach elimination targets in t... more

External Link

Vector-borne diseases: a handbook for pharmacists - Disease prevention, control, management and treatment

Gromek K., Hung M., Montero N. et al International Pharmaceutical Federation FIP (2020) C2

The Pharmaceutical Forum of the Americas (PFA) has previously published guidelines and organised campaigns for community pharmacists on the prevention, detection and control of arbovirus infections in 2018 with a grant from the FIP Foundation for Pharmacy Education and Research. Building on that exp... more

External Link

Priority Countries Consolidated Ebola Virus Disease Preparedness Checklist and Dashbord

World Health Organization (2015)

The dashboard is based on assessments made by the International Preparedness Strengthening missions to 14 priority countries against each of the activities outlined in the WHO EVD Checklist at the time of each mission. Updates indicating progress against each of the indicators will be added on an o... more

Download (125)

View PDF (78)

Political economy analysis for health financing: A ‘how to’ guide

World Health Organization (WHO) (2024) CC

This Guide is part of WHO’s overall programme of work on Political Economy of Health Financing Reform: Analysis and Strategy to Support UHC. The impetus for this work came from demands for more concrete evidence, recognition and integration of political economy issues within health financing, and... more

Download (379)

View PDF (541)

World Report 2021

Human Rights Watch HRW (2021) C1

World Report 2021, Human Rights Watch’s 31st annual review of human rights practices and trends around the globe, reviews developments in more than 100 countries. In his introductory essay, Executive Director Kenneth Roth calls on the incoming US administration to more deeply embed respect for ... more

Download (293)

View PDF (365)

Myanmar Humanitarian Situation Report #2

UNICEF UNICEF (2019)

Fighting continues to displace people in Rakhine and Shan States causing displacement of 3,700 people bringing the total displacement in the first two months of the year to approximately 7,500 people. UNICEF is restarting soap distributions in northern Rakhine State for approximately 100,000 peo... more

Download (405)

View PDF (395)

MHGAP forum and launch of the world suicide report

World Health Organization (2014) C_WHO

Sixth Meeting of the mhGAP Forum Hosted by WHO in Geneva on 4-5 September 2014 Summary Report

External Link

Integrating Clinical Research into Epidemic Response: The Ebola Experience

Gerald Keusch, Keith McAdam, Patricia Cuff, Michelle Mancher, and Emily R. Busta National Academies of Sciences, Engineering, and Medicine (2017) C1

The 2014–2015 Ebola epidemic in western Africa was the longest and most deadly Ebola epidemic in history, resulting in 28,616 cases and 11,310 deaths in Guinea, Liberia, and Sierra Leone. The Ebola virus has been known since 1976, when two separate outbreaks were identified in the Democratic Repub... more

Download (268)

View PDF (333)

Uganda: Antimicrobial Resistance National Action Plan 2018-2023

Government of Uganda (2018) C2

The current trend in AMR in Uganda and globally is rising and calls for immediate action. The 71st UN General Assembly (UNGA), the 68th World Health Assembly, and organizations including the World Health Organization (WHO), the Food and Agriculture Organization (FAO), and the World Organization for ... more

NAPHS for all: a country implementation guide for national action plan for health security (‎NAPHS)‎ - Second edition recommended

NAPHS for all: a country implementation guide for national action plan for health security (‎NAPHS)‎ - Second edition
recommended